Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1 I249/M280 -expressing retina.

Diabetic retinopathy, a microvascular disease characterized by irreparable vascular damage, neurodegeneration and neuroinflammation, is a leading complication of diabetes mellitus. There is no cure for DR, and medical interventions marginally slow the progression of disease. Microglia-mediated inflammation in the diabetic retina is regulated CX3CR1-FKN signaling, where FKN serves as a calming signal for microglial activation in several neuroinflammatory models. Polymorphic variants of , , found in 25% of the human population, result in a receptor with lower binding affinity for FKN. Furthermore, disrupted CX3CR1-FKN signaling in -KO and -KO mice leads to exacerbated microglial activation, robust neuronal cell loss and substantial vascular damage in the diabetic retina. Thus, studies to characterize the effects of -expression in microglia-mediated inflammation in the diseased retina are relevant to identify mechanisms by which microglia contribute to disease progression. Our results show that mice are significantly more susceptible to microgliosis and production of and under acute inflammatory conditions. Inflammation is exacerbated under diabetic conditions and coincides with robust neuronal loss in comparison to -WT mice. Therefore, to further investigate the role of -expression in microglial responses, we pharmacologically depleted microglia using PLX-5622, a CSF-1R antagonist. PLX-5622 treatment led to a robust (~70%) reduction in Iba1 microglia in all non-diabetic and diabetic mice. CSF-1R antagonism in diabetic -WT prevented TUJ1 axonal loss, angiogenesis and fibrinogen deposition. In contrast, PLX-5622 microglia depletion in -KO and mice did not alleviate TUJ1 axonal loss or angiogenesis. Interestingly, PLX-5622 treatment reduced fibrinogen deposition in -KO mice but not in mice, suggesting that expressing microglia influences vascular pathology differently compared to -KO microglia. Currently -KO mice are the most commonly used strain to investigate CX3CR1-FKN signaling effects on microglia-mediated inflammation and the results in this study indicate that receptor variants may serve as a complementary model to study dysregulated CX3CR1-FKN signaling. In summary, the protective effects of microglia depletion is -dependent as microglia depletion in -KO and mice did not alleviate retinal degeneration nor microglial morphological activation as observed in -WT mice.